A Message from the Director
Three Years of Progress
Here at the Taubman Institute, we are building on the momentum of three productive and exciting years.
We currently are funding four Senior Taubman Scholars and eight Taubman Scholars, who with our and your support are doing groundbreaking research that will have profound effects on the understanding and treatment of a range of diseases.
We also are working to create the collaborative environment that is one of the cornerstones of the Institute, where the exchange of ideas and creative interaction across disciplines are vigorously promoted.
This fall, for example, we kicked off our Visiting Professor lecture series with a presentation by Dr. Gary Landreth, a noted Alzheimer’s disease researcher from Case Western Reserve University. The lectures are open to the campus and about 60 students, scientists and physicians gathered to hear Dr. Landreth – who, by the way, earned one of the first three doctorates granted by U-M’s Neuroscience program.
We also hold brown-bag lunches -- where members of all the Taubman labs get together to discuss their research – and the scholars regularly gather for “chalk talks” to share, discuss and debate their findings.
And we are poised to host our fourth annual Taubman Institute Symposium on October 14 in Ann Arbor, with presentations by new Taubman scholars and a keynote address by Michigan Gov. Rick Snyder.
Throughout the coming months, I invite your continued interest in the work of the Taubman Institute. To keep up with our research and news from the laboratories, please bookmark our website at www.taubmaninsitute.org.
This is a very exciting era in the search for treatments of some of the most devastating illnesses that strike individuals and families. With the commitment of our scientists and the sustained support of people like Alfred Taubman, we are moving forward in our quest to challenge head-on some of today’s most deadly diseases.
Eva Feldman, M.D., Ph.D., FAAN
Director, Taubman Medical Research Institute
Professor of Neurology, University of Michigan Medical School
Stem cell symposium set for Sept. 19 in Ann Arbor
Dr. Eva Feldman will be among the speakers at the one-day event, which focuses on cutting-edge developments in stem-cell biology, epigenetics and regneratrive medicine.
Click here for details and registration.
New Emerging Scholar named
Scott Tomlins, M.D., an assistant profesor of pathology at U-M, has been designated the A. Alfred Taubman Emerging Scholar. Dr. Tomlins is an expert in prostate cancer research.
People who care
Institute welcomes new gift officer
Maria Muller has been appointed to work with connect donors with funding opportunities at the Taubman Institute.
Click here to read more.
news & events
Institute symposium set for Oct. 10
The A. Alfred Taubman Medical Research Institute will award the 2014 $100,000 Taubman Prize for Excellence in Translational Medical Science at its 7th annual symposium at 10 a.m. on Oct. 10.
Dr. Carl June, a physician-scientist who developed a personalized immunotherapy for leukemia using patients’ own T cells, will receive the honor and deliver the symposium's keynote address.
Click here for symposium details.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.